Brought to you by:
SVS officer elections 2022: A glimpse into the electorate
The SVS Executive Board highlights details of the most recent Society for Vascular Surgery (SVS) elections to inform members and further strengthen the process. In 2020, Society for Vascular Surgery (SVS) leadership proposed, and SVS members resoundingly approved with a…
Only a few seats remain for CPVI hands-on skills course
Only a few spots remain available for the Society for Vascular Surgery’s new Complex Peripheral Vascular Intervention (CPVI) Skills Course. Today—Thursday, Oct. 20—is the final day to register. The interactive course will be held Oct. 23 and 24 at the…
EVS 2022: Study suggests lower rates of aortic rupture, mortality after TEVAR for uncomplicated TBAD in subacute phase compared to medical management
Thoracic endovascular aortic repair (TEVAR) carried out for uncomplicated type B aortic dissections (TBAD) saw worse mortality and aortic-related outcomes when performed in the acute phase compared to those treated in the subacute phase and those managed medically. That was…
Mortality drops for acute type A aortic dissection, still high for patients not receiving surgery
The chance of a patient surviving after an acute type A aortic dissection has improved significantly, but mortality remains high if not recognized early and repaired surgically. This is according to new research from a team at Michigan Medicine at the University…
ABRE clinical study 36-month data show ‘long-term durability’ of venous stent system
Medtronic has announced the 36-month final results from the ABRE clinical study. The purpose of the ABRE clinical study was to evaluate the safety and effectiveness of the company’s Abre venous self-expanding stent system, intended for the treatment of symptomatic iliofemoral…
Six-month data from SWING below-the-knee, first-in-human trial presented at AMP Europe
Six-month data from the Surmodics SWING first-in-human (FIH) study of the company’s Sundance sirolimus drug-coated balloon (DCB) were shared at the 2022 Amputation Prevention Symposium (AMP) held Oct. 9–11 in Lugano, Switzerland. The SWING study is a prospective, multicenter, single-arm feasibility study to evaluate…
Interacting with EMR best practice advisory ‘significantly’ improves AAA screening rates
Positively interacting with best practice advisory notifications is correlated with an increased rate of abdominal aortic aneurysm (AAA) screening, according to an analysis of all patients who triggered these communications alerts in an electronic medical record (EMR) system at a…
Vascular surgeons step up for PAD awareness campaign in September
Walking is instrumental to keeping the 60,000 miles of blood vessels in the human body healthy—especially for patients with peripheral arterial disease (PAD). That is why throughout the month of September, also known as PAD Awareness Month, the Society for…
Roundtable for treating CLTI: GLASS will make it clear
The final of three roundtables on treating Chronic Limb-threatening Ischemia (CLTI) will cover the Global Limb Anatomic Staging System—GLASS. The virtual roundtable, on GLASS staging and treatment outcomes, will be held from 6 to 7:30 p.m. CDT Monday, Oct. 10.…
Terumo Aortic announces new technology add-on payment for Thoraflex Hybrid device in US
The Centers for Medicare and Medicaid Services (CMS) has granted approval of a new technology add-on payment (NTAP) for Terumo Aortic’s Thoraflex Hybrid device—used to treat aortic arch disease—under the inpatient prospective payment system (IPPS). The add-on payment is effective…